Liu Dun, Huang Xinyu, Zhang Chongyang, Wang Qin, Jiang Hua
Department of Spine Surgery, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, 430064, Hubei, China.
J Orthop Surg Res. 2024 Dec 30;19(1):891. doi: 10.1186/s13018-024-05422-3.
This study aims to perform a meta-analysis that integrates multiple literature sources to evaluate the clinical efficacy of oblique lumbar interbody fusion (OLIF) versus minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) for treating lumbar degenerative diseases (LDD).
A systematic search was conducted across various databases, including CNKI, VIP, WANFANG DATA, SinoMed, PubMed, Cochrane Library, Embase, and Web of Science, for clinical comparative studies on OLIF and MIS-TLIF for treating LDD, covering the time frame from the inception of the databases to September 2024. Following PRISMA guidelines, studies were screened, assessed, and data were extracted rigorously. Indicators extracted included operative time, intraoperative blood loss, hospital stay, visual analog scale (VAS) scores, Oswestry Disability Index (ODI), disc height (DH), segmental lordotic angle (SLA), lumbar lordosis angle (LLA), postoperative JOA scores, patient satisfaction, complication rates, and fusion rates. Meta-analysis was performed using Review Manager 5.4 software.
A total of 24 studies were included, comprising 11 randomized controlled trials and 13 retrospective cohort studies. The total population consisted of 1785 patients, with 898 in the OLIF group and 887 in the MIS-TLIF group. The meta-analysis indicated that, compared to the MIS-TLIF group, the OLIF group exhibited significantly lower intraoperative blood loss, shorter hospital stays, improved postoperative DH, shorter operative time, reduced postoperative VAS scores, lower postoperative ODI scores, and improved postoperative SLA and LLA. No significant differences were observed between the groups in postoperative JOA scores, fusion rates, complication rates, or patient satisfaction. The OLIF group exhibited advantages such as lower blood loss, shorter hospital stays, higher postoperative fusion rates, and improved recovery of disc and foraminal heights.
Compared to MIS-TLIF, OLIF is associated with a shorter operative time and less intraoperative blood loss, potentially leading to better relief of leg pain, restoration of DH, and prevention of subsidence. These findings offer valuable insights for clinical practice.
本研究旨在进行一项荟萃分析,整合多个文献来源,以评估斜外侧腰椎椎间融合术(OLIF)与微创经椎间孔腰椎椎间融合术(MIS-TLIF)治疗腰椎退行性疾病(LDD)的临床疗效。
对包括中国知网(CNKI)、维普资讯(VIP)、万方数据、中国生物医学文献数据库(SinoMed)、PubMed、考克兰图书馆、Embase和Web of Science在内的多个数据库进行系统检索,查找关于OLIF和MIS-TLIF治疗LDD的临床对比研究,检索时间范围为各数据库建库至2024年9月。按照PRISMA指南,严格筛选、评估研究并提取数据。提取的指标包括手术时间、术中出血量、住院时间、视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI)、椎间盘高度(DH)、节段性前凸角(SLA)、腰椎前凸角(LLA)、术后日本骨科学会(JOA)评分、患者满意度、并发症发生率和融合率。使用Review Manager 5.4软件进行荟萃分析。
共纳入24项研究,其中包括11项随机对照试验和13项回顾性队列研究。总样本量为1785例患者,OLIF组898例,MIS-TLIF组887例。荟萃分析表明,与MIS-TLIF组相比,OLIF组术中出血量显著减少、住院时间缩短、术后DH改善、手术时间缩短、术后VAS评分降低、术后ODI评分降低,术后SLA和LLA改善。两组在术后JOA评分、融合率、并发症发生率或患者满意度方面未观察到显著差异。OLIF组具有出血量少、住院时间短、术后融合率高以及椎间盘和椎间孔高度恢复良好等优势。
与MIS-TLIF相比,OLIF手术时间更短,术中出血量更少,可能导致腿痛更好缓解、DH恢复以及预防椎体下沉。这些发现为临床实践提供了有价值的见解。